Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
clinical trials
fda
2
×
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
avapritinib
biotech
blueprint medicines
cstone pharmaceuticals
deals
drugs
eli lilly
european medicines agency
fisogatinib
flatiron health
genentech
givosiran
hepatocellular carcinoma
investing
jeff albers
medullary thyroid cancer
national top stories
non-small cell lung cancer
onpattro
patisiran
paul matteis
pralsetinib
rna interference
roche
san francisco blog main
san francisco top stories
selpercatinib
stifel financial
thermo fisher scientific
What
approval
2
×
drug
fda
ago
alnylam
blueprint
cancer
candidate
currently
indicated
interference
marketing
medicine
medicines
muscle
nod
pact
pharmaceuticals
quick
regulatory
ret
review
rna
rnai
roche
second
seek
speedy
team
weeks
wins
won’t
Language
unset
Current search:
boston
×
fda
×
approval
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug